ValiRx plc

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Show More...

Website https://www.valirx.com
Sector Healthcare
Industry Biotechnology
Last Quote 0.55 GBX
Last Updated 30-05-2025
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2009-12	2010-12	2011-12	2012-12	2013-12	2014-12	2015-12	2016-12	2017-12	2018-12	TTM
Earnings Per Share GBP	-187.5	15.63	-15.63	-26.56	-23.44	-16.85	-8.32	-10.28	-2.38	-1.18	-0.68
Dividends GBP
Payout Ratio % *
Shares Mil									1.0	4.0	5.0
Book Value Per Share * GBP		63.51	73.45	45.99	26.51	21.98	9.88	5.03	0.71	0.81	0.1
Free Cash Flow Per Share * GBP		-32.51	-53.12	-19.31	-19.19	-15.77	-11.06	-5.48	-4.36	-1.54
Return on Assets %	-83.7	6.43	-26.41	-43.87	-55.23	-81.76	-48.45	-94.17	-61.01	-93.74	-69.47
Financial Leverage (Average)	1.84	1.25	1.03	1.05	1.27	1.31	1.15	2.11	1.55	1.36	1.26
Return on Equity %	-126.63	9.23	-29.06	-45.75	-62.83	-105.47	-58.72	-139.57	-109.27	-136.43	-85.23
Return on Invested Capital %	-122.8	9.63	-29.58	-46.12	-62.95	-105.67	-58.7	-94.68	-72.74	-122.7	-82.58
Interest Coverage	-420.67	24.25	-531.5					-16.01	-6.9		-356.5
Current Ratio	0.25	1.83	13.73	10.0	1.66	1.49	4.12	0.82	1.12	0.84	0.94
Quick Ratio	0.21	1.72	13.42	9.18	1.27	0.83	0.78	0.52	0.78	0.37	0.34
Debt/Equity

ValiRx plc

Interest Coverage